RU2130971C1 - Рекомбинантный вектор на основе вируса оспы птиц, рекомбинантный вектор для вакцинации домашней птицы - Google Patents

Рекомбинантный вектор на основе вируса оспы птиц, рекомбинантный вектор для вакцинации домашней птицы Download PDF

Info

Publication number
RU2130971C1
RU2130971C1 SU5052222A SU5052222A RU2130971C1 RU 2130971 C1 RU2130971 C1 RU 2130971C1 SU 5052222 A SU5052222 A SU 5052222A SU 5052222 A SU5052222 A SU 5052222A RU 2130971 C1 RU2130971 C1 RU 2130971C1
Authority
RU
Russia
Prior art keywords
virus
sequence
tir
protein
recombinant
Prior art date
Application number
SU5052222A
Other languages
English (en)
Russian (ru)
Inventor
Тири Жорж
Коло Дидье
Де Ваннемаекер Катрин
Маларм Даниель
Original Assignee
Димминако АГ/СА/Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Димминако АГ/СА/Лтд. filed Critical Димминако АГ/СА/Лтд.
Application granted granted Critical
Publication of RU2130971C1 publication Critical patent/RU2130971C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SU5052222A 1991-05-27 1992-05-27 Рекомбинантный вектор на основе вируса оспы птиц, рекомбинантный вектор для вакцинации домашней птицы RU2130971C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE09100507 1991-05-27
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (1)

Publication Number Publication Date
RU2130971C1 true RU2130971C1 (ru) 1999-05-27

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
SU5052222A RU2130971C1 (ru) 1991-05-27 1992-05-27 Рекомбинантный вектор на основе вируса оспы птиц, рекомбинантный вектор для вакцинации домашней птицы

Country Status (23)

Country Link
EP (1) EP0517292B1 (enExample)
JP (1) JP3411307B2 (enExample)
KR (1) KR100244601B1 (enExample)
CN (1) CN1055501C (enExample)
AR (1) AR248045A1 (enExample)
AT (1) ATE189480T1 (enExample)
AU (1) AU656185B2 (enExample)
BE (1) BE1004877A3 (enExample)
BR (1) BR9202024A (enExample)
CA (1) CA2069594A1 (enExample)
DE (1) DE69230627T2 (enExample)
DK (1) DK0517292T3 (enExample)
ES (1) ES2145000T3 (enExample)
HU (1) HU215531B (enExample)
IE (1) IE921686A1 (enExample)
IL (1) IL101780A (enExample)
MX (1) MX9202512A (enExample)
NZ (1) NZ242620A (enExample)
PT (1) PT517292E (enExample)
RU (1) RU2130971C1 (enExample)
SG (1) SG49876A1 (enExample)
TW (1) TW288048B (enExample)
ZA (1) ZA923321B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2264708C2 (ru) * 2001-04-17 2005-11-27 Эмбрекс, Инк. Способ обработки яиц (варианты)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110505A1 (en) * 1991-07-26 1993-02-18 Enzo Paoletti Infectious bursal disease virus recombinant poxvirus vaccine
ATE286137T1 (de) * 1992-01-13 2005-01-15 Virogenetics Corp Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
EP1450854A2 (en) 2001-11-30 2004-09-01 Isis Innovation Limited Vaccine
PL216760B1 (pl) * 2002-05-16 2014-05-30 Bavarian Nordic As Rekombinowany modyfikowany wirus krowianki Ankara oraz sposób jego otrzymywania i zastosowania
EP1601333B1 (en) * 2003-02-20 2013-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Novel insertion sites in pox vectors
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
EP2785373B1 (en) 2011-11-30 2019-11-20 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
EP3263129A1 (en) 2016-06-29 2018-01-03 Ceva Sante Animale Duck enteritis virus and the uses thereof
CN117357642A (zh) 2016-12-14 2024-01-09 勃林格殷格翰动物保健美国公司 表达禽病原体的多种抗原的重组hvt载体及其用途
CN113347992A (zh) 2018-12-27 2021-09-03 法国诗华大药厂 重组病毒和其用途
MA58717A1 (fr) 2020-06-17 2023-06-28 Boehringer Ingelheim Vetmedica Gmbh Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations
TWI812936B (zh) 2021-04-01 2023-08-21 智勝科技股份有限公司 研磨墊及研磨方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
WO1990002191A1 (en) * 1988-08-26 1990-03-08 Applied Biotechnology, Inc. Recombinant fowlpox virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
US5310671A (en) * 1988-06-24 1994-05-10 British Technology Group Limited Fowlpox virus non-essential regions
AU623476B2 (en) * 1988-12-29 1992-05-14 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
AU643216B2 (en) * 1989-05-30 1993-11-11 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
WO1990002191A1 (en) * 1988-08-26 1990-03-08 Applied Biotechnology, Inc. Recombinant fowlpox virus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2264708C2 (ru) * 2001-04-17 2005-11-27 Эмбрекс, Инк. Способ обработки яиц (варианты)

Also Published As

Publication number Publication date
ZA923321B (en) 1993-01-27
EP0517292A1 (fr) 1992-12-09
HUT62331A (en) 1993-04-28
AU656185B2 (en) 1995-01-27
IL101780A (en) 2000-12-06
ATE189480T1 (de) 2000-02-15
CA2069594A1 (fr) 1992-11-28
TW288048B (enExample) 1996-10-11
HU215531B (hu) 2000-05-28
EP0517292B1 (fr) 2000-02-02
DK0517292T3 (da) 2000-05-08
PT517292E (pt) 2000-06-30
HU9201746D0 (en) 1992-08-28
JPH05244939A (ja) 1993-09-24
MX9202512A (es) 1995-01-31
BE1004877A3 (fr) 1993-02-16
DE69230627T2 (de) 2000-09-28
ES2145000T3 (es) 2000-07-01
IL101780A0 (en) 1992-12-30
CN1069068A (zh) 1993-02-17
BR9202024A (pt) 1993-01-19
NZ242620A (en) 1993-09-27
JP3411307B2 (ja) 2003-05-26
DE69230627D1 (de) 2000-03-09
IE921686A1 (en) 1992-12-02
AR248045A1 (es) 1995-05-31
KR100244601B1 (ko) 2000-03-02
CN1055501C (zh) 2000-08-16
KR920021706A (ko) 1992-12-18
SG49876A1 (en) 2002-04-16
AU1632392A (en) 1992-12-03

Similar Documents

Publication Publication Date Title
RU2130971C1 (ru) Рекомбинантный вектор на основе вируса оспы птиц, рекомбинантный вектор для вакцинации домашней птицы
KR0179994B1 (ko) 칠면조의 재조합 포진바이러스 및 이로부터 유도된 생존상태의 벡터 백신
RU2766003C2 (ru) Мультивалентные рекомбинантные вирусы птичьего герпеса и вакцины для иммунизации птиц
EP0968297B1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US10188720B2 (en) Recombinant Marek's disease viruses and uses thereof
JPH10506782A (ja) 組換え型シチメンチョウヘルペスウイルス、及びその使用
EP0914458A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US10821170B2 (en) Duck Enteritis Virus and the uses thereof
JPH08500969A (ja) 七面鳥の組換えヘルペスウイルス及びそれらの使用
CA2166371A1 (en) Avian herpesvirus-based live recombinant avian vaccine, in particular against gumboro disease
HUT62325A (en) Chicken anaemia virus vaccine and diagnostic
US6913751B2 (en) Recombinant avian herpesvirus useful in vaccine production
CA2110505A1 (en) Infectious bursal disease virus recombinant poxvirus vaccine
DE69227860T2 (de) Rekombinante Geflügelpockenvazzine zum Schutz gegen die Marek-Krankheit
US20100008948A1 (en) Recombinant herpesvirus useful in vaccine production
US10246685B2 (en) Recombinant MDV1 and the uses thereof
US6241989B1 (en) Recombinant multivalent viral vaccine
US7087234B1 (en) Recombinant multivalent viral vaccine
JPH07255488A (ja) 組換えマレック病ウイルスおよびその作出法
JPH06141853A (ja) 組換え鶏伝染性喉頭気管炎ウイルス及びその製法
JPH05244940A (ja) 組み換えアビポックスウィルス及びそれから成るワクチン